Compare AEI & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AEI | BHST |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | United States | Canada |
| Employees | N/A | 87 |
| Industry | Building operators | |
| Sector | Real Estate | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.4M | 97.7M |
| IPO Year | 2019 | N/A |
| Metric | AEI | BHST |
|---|---|---|
| Price | $1.75 | $4.27 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 16.3K | ★ 26.9K |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $16,238,200.00 | N/A |
| Revenue This Year | N/A | $146.27 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.77 | $4.10 |
| 52 Week High | $4.55 | $12.80 |
| Indicator | AEI | BHST |
|---|---|---|
| Relative Strength Index (RSI) | 45.26 | 44.99 |
| Support Level | $1.47 | $4.27 |
| Resistance Level | $2.11 | $5.02 |
| Average True Range (ATR) | 0.16 | 0.13 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 36.00 | 12.50 |
Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.